Definitive radiotherapy plus regional hyperthermia for high-risk and very high-risk prostate carcinoma: Thermal parameters correlated with biochemical relapse-free survival

References

• Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D’Amico AV, et al. Prostate cancer, Version 3.2012: Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2012;10:1081–7
   PubMed Web of Science ®Google Scholar
• Payne H, Mason M. Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: Recent developments. Br J Cancer 2011;105:1628–34
   PubMed Web of Science ®Google Scholar
• Heijkoop ST, van Doorn HC, Stalpers LJ, Boere IA, van der Velden J, Franckena M, et al. Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation. Int J Hyperthermia 2014;30:6–10
   PubMed Web of Science ®Google Scholar
• Inman BA, Stauffer PR, Craciunescu OA, Maccarini PF, Dewhirst MW, Vujaskovic Z. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 2014;30:171–5
   PubMed Web of Science ®Google Scholar
• Sousa A, Inman BA, Pineiro I, Monserrat V, Perez A, Aparici V, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:166–70
   PubMed Web of Science ®Google Scholar
• Jones EL, Samulski TV, Leonard RP, Dewhirst MW: Hyperthermia, 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2003
   Google Scholar
• van der Zee J. Heating the patient: A promising approach? Ann Oncol 2002;13:1173–84
   PubMed Web of Science ®Google Scholar
• Hurwitz M, Stauffer P. Hyperthermia, radiation and chemotherapy: The role of heat in multidisciplinary cancer care. Semin Oncol 2014;41:714–29
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3:487–97
   PubMed Web of Science ®Google Scholar
• Ben-Hur E, Elkind MM. Thermally enhanced radioresponse of cultured Chinese hamster cells: Damage and repair of single-stranded DNA and a DNA complex. Radiat Res 1974;59:484–95
   PubMed Web of Science ®Google Scholar
• Sherar M, Liu FF, Pintilie M, Levin W, Hunt J, Hill R, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: Data from a phase III trial. Int J Radiat Oncol Biol Phys 1997;39:371–80
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Hansen JL, Prokopios-Davos S, Manola J, Wang Q, Bornstein BA, et al. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: Long-term results from Dana-Farber Cancer Institute study 94–153. Cancer 2011;117:510–16
   PubMed Web of Science ®Google Scholar
• Anscher MS, Samulski TV, Dodge R, Prosnitz LR, Dewhirst MW. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997;37:1059–65
   PubMed Web of Science ®Google Scholar
• Van Vulpen M, De Leeuw AA, Raaymakers BW, Van Moorselaar RJ, Hofman P, Lagendijk JJ, et al. Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: Preliminary results. BJU Int 2004;93:36–41
   PubMed Web of Science ®Google Scholar
• Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, et al. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005;181:35–41
   PubMed Web of Science ®Google Scholar
• Maluta S, Dall'Oglio S, Romano M, Marciai N, Pioli F, Giri MG, et al. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study. Int J Hyperthermia 2007;23:451–6
   PubMed Web of Science ®Google Scholar
• Deger S, Taymoorian K, Boehmer D, Schink T, Roigas J, Wille AH, et al. Thermoradiotherapy using interstitial self-regulating thermoseeds: An intermediate analysis of a phase II trial. Eur Urol 2004;45:574–9; discussion 580
   PubMed Web of Science ®Google Scholar
• Song CW, Rhee JG, Lee CK, Levitt SH. Capacitive heating of phantom and human tumors with an 8 MHz radiofrequency applicator (Thermotron RF-8). Int J Radiat Oncol Biol Phys 1986;12:365–72
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Jo S, Akuta K, Nishimura Y, Takahashi M, Abe M. Radiofrequency capacitive hyperthermia for deep-seated tumors. I. Studies on thermometry. Cancer 1987;60:121–7
   Google Scholar
• Abe M, Hiraoka M, Takahashi M, Egawa S, Matsuda C, Onoyama Y, et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 1986;58:1589–95
   PubMed Web of Science ®Google Scholar
• Oleson JR, Samulski TV, Leopold KA, Clegg ST, Dewhirst MW, Dodge RK, et al. Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993;25:289–97
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005;23:3079–85
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003;19:267–94
   PubMed Web of Science ®Google Scholar
• de Bruijne M, van der Holt B, van Rhoon GC, van der Zee J. Evaluation of CEM43 degrees CT90 thermal dose in superficial hyperthermia: A retrospective analysis. Strahlenther Onkol 2010;186:436–43
   PubMed Web of Science ®Google Scholar
• Roach M III, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65:965–74
   PubMed Web of Science ®Google Scholar
• Triantopoulou S, Efstathopoulos E, Platoni K, Uzunoglou N, Kelekis N, Kouloulias V. Radiotherapy in conjunction with superficial and intracavitary hyperthermia for the treatment of solid tumors: Survival and thermal parameters. Clin Transl Oncol 2013;15:95–105
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995;345(8949):540–3
   Google Scholar
• Franckena M, Fatehi D, de Bruijne M, Canters RA, van Norden Y, Mens JW, et al. Hyperthermia dose–effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 2009;45:1969–78
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Yahara K, Morioka T, Nakano K, Terashima H, et al. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: The radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes. Int J Radiat Oncol Biol Phys 2009;73:128–35
   PubMed Web of Science ®Google Scholar
• Rau B, Wust P, Tilly W, Gellermann J, Harder C, Riess H, et al. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: Regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 2000;48:381–91
   PubMed Web of Science ®Google Scholar
• Kroeze H, van de Kamer JB, de Leeuw AA, Kikuchi M, Lagendijk JJ. Treatment planning for capacitive regional hyperthermia. Int J Hyperthermia 2003;19:58–73
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Yahara K, Kakeda S, Tomimatsu A, Kato F, et al. Effect of 8-MHz radiofrequency-capacitive regional hyperthermia with strong superficial cooling for unresectable or recurrent colorectal cancer. Int J Hyperthermia 2004;20:465–75
   PubMed Web of Science ®Google Scholar
• Ohguri T, Yahara K, Moon SD, Yamaguchi S, Imada H, Terashima H, et al. Deep regional hyperthermia for the whole thoracic region using 8 MHz radiofrequency-capacitive heating device: Relationship between the radiofrequency-output power and the intra-oesophageal temperature and predictive factors for a good heating in 59 patients. Int J Hyperthermia 2011;27:20–6
   PubMed Web of Science ®Google Scholar
• van der Zee J, Peer-Valstar JN, Rietveld PJ, de Graaf-Strukowska L, van Rhoon GC. Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys 1998;40:1205–12
   PubMed Web of Science ®Google Scholar
• Fatehi D, van der Zee J, Notenboom A, van Rhoon GC. Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors. Strahlenther Onkol 2007;183:479–86
   PubMed Web of Science ®Google Scholar
• Stroup SP, Cullen J, Auge BK, L'Esperance JO, Kang SK. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition. Cancer 2007;110:1003–9
   PubMed Web of Science ®Google Scholar
• Amling CL. Relationship between obesity and prostate cancer. Curr Opin Urol 2005;15:167–71
   PubMed Web of Science ®Google Scholar
• Merrick GS, Galbreath RW, Butler WM, Wallner KE, Allen ZA, Adamovich E. Obesity is not predictive of overall survival following permanent prostate brachytherapy. Am J Clin Oncol 2007;30:588–96
   PubMed Web of Science ®Google Scholar
• Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR. The impact of obesity on overall and cancer specific survival in men with prostate cancer. J Urol 2009;182:112–17; discussion:117
   PubMed Web of Science ®Google Scholar
• Geinitz H, Riegel MG, Thamm R, Astner ST, Lewerenz C, Zimmermann F, et al. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy. Int J Radiat Oncol Biol Phys 2011;82:1930–7
   PubMed Web of Science ®Google Scholar
• Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: Weighing the evidence. Eur Urol 2013;63:800–9
   PubMed Web of Science ®Google Scholar